Research Groups
Criteria for ESPT Membership
The strong linkage between Research Teams, Research Groups working in the field and ESPT will represent the scientific image of our organization.
The Research groups representing one or two domains important for Pharmacogenomics and Personalized Medicine:
- Will be put with the best possible visibility on our Web site and in documents. The activities of the research group will be described shortly on the web with the updated publications of the members
- The group is constituted of a leader, who have to be ESPT full member and 10-30 associate members
All members have full access to all ESPT activities (Restricted area on the ESPT web site (DMPT, teaching platform) and Reductions for courses, schools and meetings)
- The members particularly the young members will be strongly associated with the scientific activities of ESPT (Annual meetings)
- They could participate and propose new committees. This strategy will support also dynamically the carriers of young co-workers
The annual membership fee: 20 € per Associate member and 85 € for the leader(s)
Research Groups
For more information about the research group, please click on the name of the group.
| Name | Location | Contact |
| CANSEARCH research Laboratory | Geneva, Switzerland | Marc Ansari |
| Center for Pharmacogenomics – The Ohio State University | Columbus, USA | Wolfgang Sadee |
| Extremadura University Hospital and Medical School, Badajoz - CICAB Clinical Research Center | Badajoz, Spain | Adrian Llerena |
| Karolinska Institute – Department of Physiology and Pharmacology | Stockholm, Sweden | Magnus Ingelman-Sundberg |
| Lab Applied Molecular Biology and Pharmacogenomics - University of Sao Paulo | Sao Paulo, Brazil | Rosario Hirata |
| Labex –Institut de Biologie de Lille – CNRS UMR 8199 | Lille, France | Philippe Froguel |
| Laboratoire d’hématologie – CHU Timone | Marseille, France | Pierre Morange / Marie-Christine Alessi |
| Pharmacogenetics Research Group Rotterdam | Rotterdam, The Netherlands | Ron H.N. Van Schaik |
| Pharmacogenomics laboratory - Research Center CHUQ (CHUL) – Laval University Faculty of Pharmacy | Quebec, Canada | Chantal Guillemette |
| UMR INSERM U 1122 Interactions Gène-Environnement en Physiopathologie Cardio-Vasculaire (IGE-PCV) | Nancy, France | Sophie Siest |
| University of Ljubljana, Faculty of Pharmacy research group | Ljubljana, Slovenia | Janja Marc |
Discussions going on
| Name |
Location |
Contact |
| Omics Science Center – RIKEN Yokohama Institute | Yokohama, Japan | Toshihisa Ishikawa |
| Luxembourg Centre for Systems Medicine | Luxembourg | Jochen Schneider |
|
Paris Team Pharmacogénomique des anticoagulants |
France | Marie-Anne Loriot/ Virginie Siguret / Pascale Gaussem |
| Charles Auffray | Lyon, France | Maria Nogueira |
| Leiden Academic Centre for Drug Research - Leiden University Medical Center | Leiden, The Netherlands | H.J. Guchelaar/ J.J. Swen |
| Slovakian Research Group | Slovakia | Ivan Tkac |
| IKP Stuttgart – Institut für Klinische Pharmakologie Stuttgart | Germany | Matthias Schwab |
| Institute for Pharmacology and Toxicology Center for Pharmacogenetics and Pharmacogenomics - Paracelsus Medical University | Salzburg, Austria | Markus Paulmichl |
| Centre Energie Atomique - Saclay | Gif sur Yvette, France | Isabelle Philippe |
| Department of Molecular and Clinical Pharmacology – The Wolfson Centre for Personalised Medicine – Institute of Translational Medicine – University of Liverpool | Liverpool, United Kingdom | Munir Pirmohamed |
| Department of Neurosciences, Mental Health and Sensory Organs - Sapienza University of Rome | Rome, Italy | Maurizio Simmaco |